Latest Articles
MWC team awarded funding for COVID-19 research
3 May 2020
MWC researchers at the University of Auckland have been awarded Auckland Medical Research Foundation (AMRF) funding to investigate whether certain types of patent could be used for COVID-19 antiviral drug development.
read more
MWC link to promising COVID-19 treatment
24 April 2020
Professor Peter Tyler, MWC Associate Investigator at the Ferrier Research Institute, Victoria University of Wellington, created the antiviral drug Galidesivir which is in the front-running for potential use in the treatment of COVID-19.
read more
COVID-19 antiviral drugs needed now - MWC researchers
24 April 2020
A group of scientific experts from around New Zealand featuring several investigators from the Maurice Wilkins Centre is calling on the Government to acquire antiviral therapies effective against any future COVID-19 resurgence.
read more
MWC researcher explains COVID-19 origins
14 April 2020
Dr Jemma Geoghegan, MWC researcher and Senior Lecturer in the Department of Microbiology and Immunology at the University of Otago, has given expert COVID-19 commentary that has been picked up by media in New Zealand and internationally.
read more
COVID-19 vaccine development – comment
11 April 2020
More than 50 COVID-19 vaccines are under development in research laboratories worldwide. Much of this work is being fast-tracked. However, how likely is it that a vaccine will become available any time soon?
read more
Take COVID-19 lockdown seriously - MWC investigator
25 March 2020
Professor Michael Baker, MWC Associate Investigator at the University of Otago's Department of Public Health, has played a leading role in providing COVID-19-related public health advice to New Zealanders.
read more
MWC investigators developing COVID-19 tests
19 March 2020
Maurice Wilkins Centre researchers are responding to the COVID-19 crisis, developing tools to fight the disease.
read more